Amgen expands crackdown on what it says is misuse of 340B program

May 15, 2026 01:31 PM EDT Pharma Am­gen ex­pands crack­down on what it says is mis­use of 340B pro­gram Nicole DeFeudis Senior Reporter Am­gen is ex­pand­ing its claims da­ta re­quire­ments for phar­ma­cies dis­pens­ing its drugs un­der the 340B fed­er­al drug dis­count pro­gram. The com­pa­ny said the new pol­i­cy … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER